HOME >> MAGEE PRIZE
The 2024 Magee Prize Finalists
We are pleased to announce the finalists for the $1 million Magee Prize, which funds new research initiatives and transdisciplinary collaborations to advance women’s and reproductive health.
The following projects were selected by an external review committee as the 2024 Magee Prize finalists:
“EGFL6: A Link Between Obesity, High-Risk Endometrial Cancer, and Racial Disparities”
Ronald Buckanovich MD, PhD (MWRI) with Co-PIs: Bo Rueda, PhD (Harvard University) and Victoria Bae-Jump MD, PhD (University of North Carolina)
“Role of Placental Small Extracellular Vesicles in Disrupting the Blood-Brain-Barrier and Impairing Cognition in Women with Preeclampsia”
Carlos Escudero Orozco, MD, PhD with Co-PIs: Janet Catov, PhD (MWRI), Lina Bergman, MD, PhD (University of Gothenburg, Sweden), Manu Vatish, MD, PhD (Oxford University, UK) and Jeffrey Penny, PhD (Manchester University, UK)
“Next-Generation IVF: Unveiling Optimal In Vitro Maturation Protocols for Immature Oocytes”
Julie Rios, MD (MWRI) with Co-PI: Rebecca Flyckt, MD (Case Western University/Cleveland Medical Center)
The 2024 Magee Prize will be presented during the Magee-Womens Summit on November 13-14, 2024. The principal investigators of the top three projects will present their proposals, and the winning team will be announced after a vote by conference attendees.
2021 Magee Prize Winning Team
The 2021 Magee Prize, a $1 million award, was granted to an international team led by Dr. Pamela Moalli, Director of Urogynecology and Pelvic Reconstruction Surgery at UPMC Magee-Womens Hospital and Magee-Womens Research Institute.
The team's groundbreaking research focused on developing innovative biomaterials to repair tissue loss in women facing compromised vaginal structure and function resulting from pelvic cancers, ovariectomy, chemotherapy, or radiation treatments.
2018 Magee Prize Winning Team
The 2018 Magee Prize went to a University of Pittsburgh team led by Dr. Yaacov Barak.
The team utilized the $1 million Magee Prize from the Richard King Mellon Foundation to investigate how placental defects may lead to congenital heart disease, aiming to identify early interventions to correct or prevent such defects.